Bharat Biotech Successfully Ships out COVAXIN™ to 11 cities, donates 16.5 Lakh doses to the Government
Hyderabad, India, January 13, 2021: Bharat Biotech has announced the successful air-shipment of COVAXIN™, to 11 cities in India in the early hours of Wednesday. Bharat Biotech has also donated 16.5 Lakh doses to the Government of India.
Bharat Biotech’s ‘COVAXIN™’ Emergency Use Authorization approval by DCGI-CDSCO, MoH&FW, a significant landmark in India’s Scientific Discovery, and Scientists Capability
Dr. Krishna Ella said “The approval of COVAXIN™ for emergency use is a giant leap for Innovation and novel product development in India. It is a proud moment for the nation and a great milestone in India’s scientific capability, a kickstart to the innovation ecosystem in India. While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. COVAXIN™ has generated excellent safety data with robust immune responses to multiple viral proteins that persist.”
India’s biggest bio entrepreneurship platform, NBEC 2020 crowns 14 winners after an intense four-month-long competition
The winners in the student-team innovation category were Tanish T. Sridhar who won the Persistent Systems sponsored cash prize of 5 lakhs INR, Chandan Kumar Jha who won the BIRAC cash prize of 3 lakhs INR, and Abduljabbar Khan who won 2 lakhs INR in a pooled prize by K&S partners, Bioneeds and Ideaspring Capital.